Report overview
Aneurysmal subarachnoid hemorrhage (aSAH) is a life-threatening type of stroke caused by bleeding in the space surrounding the brain.
This report aims to provide a comprehensive presentation of the global market for Aneurysmal Subarachnoid Hemorrhage Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Aneurysmal Subarachnoid Hemorrhage Drugs. This report contains market size and forecasts of Aneurysmal Subarachnoid Hemorrhage Drugs in global, including the following market information:
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Sales, 2018-2023, 2024-2029, (K MT)
Global top five Aneurysmal Subarachnoid Hemorrhage Drugs companies in 2022 (%)
The global Aneurysmal Subarachnoid Hemorrhage Drugs market was valued at US$ 154.9 million in 2022 and is projected to reach US$ 176.9 million by 2029, at a CAGR of 1.9% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The global aneurysmal subarachnoid hemorrhage drugs market is segmented based on drug class and region. Based on drug class, the market is segmented into opioid analgesic, calcium channel blocker, anticonvulsant, stool softener, osmotic agent/diuretic, and other drugs.
We surveyed the Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, by Type, 2022 (%)
Opioid Analgesic
Calcium Channel Blocker
Anticonvulsant
Stool Softener
Osmotic Agent
Other Drugs
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, by Application, 2022 (%)
Hospital
Clinic
Others
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K MT)
Global Aneurysmal Subarachnoid Hemorrhage Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs revenues share in global market, 2022 (%)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs sales in global market, 2018-2023 (Estimated), (K MT)
Key companies Aneurysmal Subarachnoid Hemorrhage Drugs sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Arbor Pharmaceuticals
PDS Biotechnology Corporation
Johnson and Johnson
Mylan N.V
Orexo AB
Pfizer
Purdue Pharma
Pharmaxis
Sun Pharmaceutical Industries
Teva Pharmaceutical
Outline of Major Chapters:
Chapter 1: Introduces the definition of Aneurysmal Subarachnoid Hemorrhage Drugs, market overview.
Chapter 2: Global Aneurysmal Subarachnoid Hemorrhage Drugs market size in revenue and volume.
Chapter 3: Detailed analysis of Aneurysmal Subarachnoid Hemorrhage Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Aneurysmal Subarachnoid Hemorrhage Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Aneurysmal Subarachnoid Hemorrhage Drugs capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.
